Evidence mapPaperPMID 22990274Full record

ArticleJAMA2012

Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults.

Ian J Neeland, Aslan T Turer, Colby R Ayers, Tiffany M Powell-Wiley, Gloria L Vega, Ramin Farzaneh-Far, Scott M Grundy, Amit Khera, Darren K McGuire, James A de Lemos

2 registry-linked trialsAbstract read
In one paragraph

Article in JAMA, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 331 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
331citing papers in PubMed, 16 pooled it
29.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02833415 phase4completedstarted 2016, after this paper: background citation

Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging

Ran2016Enrolled40Registered outcomes1Posted comparisons2ConditionsObesity, VisceralArmsempagliflozin, Placebo (for Empagliflozin), [U-13C3] glycerol
Open the trial in the graph
NCT03038620 phase4completedstarted 2017, after this paper: background citation

Impact of Liraglutide 3.0 on Body Fat Distribution, Visceral Adiposity, and Cardiometabolic Risk Markers In Overweight and Obese Adults at High Risk for Cardiovascular Disease

Ran2017Enrolled235Registered outcomes37Posted comparisons0ConditionsCardiovascular Diseases, Fat Disorder, Obesity, VisceralArmsliraglutide, Placebo
Open the trial in the graph
3 · Its place in the literature

Who cites it

331 citing papers in PubMed, 16 syntheses or guidelines pooled it, 646 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Trial
  18. Trial
  19. Trial
  20. Trial

271 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ian J NeelandDivision of Cardiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8830, USA.
Aslan T Turer
Colby R Ayers
Tiffany M Powell-Wiley
Gloria L Vega
Ramin Farzaneh-Far
Scott M Grundy
Amit Khera
Darren K McGuire
James A de Lemos
National Institutes of Health · USThe University of Texas Southwestern Medical Center · US

Funding

XU 40468 IN HYPERCHOLESTEROLEMIAM01RR000633 · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · 1985 to 2005
$17.2M
TRAINING IN CARDIOVASCULAR RESEARCHT32HL007360 · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · 1985 to 2005
$5.9M
Intramural NIH HHS Z99 HL999999NCATS NIH HHS UL1 TR000451NCATS NIH HHS UL1 TR001105NCRR NIH HHS M01 RR000633NCRR NIH HHS M01-RR00633NHLBI NIH HHS T32 HL007360NHLBI NIH HHS T32HL007360NIDCR NIH HHS UL1 DE019584NIDCR NIH HHS UL1DE019584NIDDK NIH HHS PL1 DK081182NIDDK NIH HHS PL1DK081182
6 · The paper itself

Abstract

contextThe risk of type 2 diabetes mellitus is heterogeneous among obese individuals. Factors that discriminate prediabetes or diabetes risk within this population have not been well characterized. A dysfunctional adiposity phenotype, characterized by excess visceral fat and insulin resistance, may contribute to diabetes development in those with obesity.

objectiveTo investigate associations between adiposity phenotypes and risk for incident prediabetes and diabetes in a multiethnic, population-based cohort of obese adults. DESIGN, SETTING, AND

participantsAmong 732 obese participants (body mass index ≥30) aged 30 to 65 years without diabetes or cardiovascular disease enrolled between 2000 and 2002 in the Dallas Heart Study, we measured body composition by dual energy x-ray absorptiometry and magnetic resonance imaging (MRI); circulating adipokines and biomarkers of insulin resistance, dyslipidemia, and inflammation; and subclinical atherosclerosis and cardiac structure and function by computed tomography and MRI.

main outcome measuresIncidence of diabetes through a median 7.0 years (interquartile range, 6.6-7.6) of follow-up. In a subgroup of 512 participants with normal fasting glucose values at baseline, incidence of the composite of prediabetes or diabetes was determined.

resultsOf the 732 participants (mean age, 43 years; 65% women; 71% nonwhite), 84 (11.5%) developed diabetes. In multivariable analysis, higher baseline visceral fat mass (odds ratio [OR] per 1 SD [1.4 kg], 2.4; 95% CI, 1.6-3.7), fructosamine level (OR per 1 SD [1.1 μmol/L], 2.0; 95% CI, 1.4-2.7), fasting glucose level (OR per 1 SD [1.1 μmol/L], 1.9; 95% CI, 1.4-2.6), family history of diabetes (OR, 2.3; 95% CI, 1.3-4.3), systolic blood pressure (OR per 10 mm Hg, 1.3; 95% CI, 1.1-1.5), and weight gain over follow-up (OR per 1 kg, 1.06; 95% CI, 1.02-1.10) were independently associated with diabetes, with no associations observed for body mass index, total body fat, or abdominal subcutaneous fat. Among the 512 participants with normal baseline glucose values, the composite outcome of prediabetes or diabetes occurred in 39.1% and was independently associated with baseline measurements of visceral fat mass; levels of fasting glucose, insulin, and fructosamine; older age; nonwhite race; family history of diabetes; and weight gain over follow-up (P < .05 for each) but not with measurements of general adiposity.

conclusionExcess visceral fat and insulin resistance, but not general adiposity, were independently associated with incident prediabetes and type 2 diabetes mellitus in obese adults.

Indexed as

AdiposityInsulin ResistanceIntra-Abdominal FatAdultAgedBiomarkersBody CompositionCohort StudiesDiabetes Mellitus, Type 2FemaleHumansMagnetic Resonance ImagingMaleMiddle AgedObesityPhenotypeBiomarkers

Identifiers

PMID22990274
PMCPMC3556508
OpenAlexW2030795765

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.